ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

42 links2 made here, not in the record96 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govReplaced, or read an older versionMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT02925234The Drug RediscoveryProtocol (DRUP Trial)The Netherlands Cancer InstituPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSNeoplasmsThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSPanitumumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedOlaparibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedDabrafenibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedNilotinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTrametinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedErlotinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTrastuzumabEntry “Trastuzumab and Pertuzumab (co…›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPertuzumabEntry “Trastuzumab and Pertuzumab (co…›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedVemurafenibEntry “Vemurafenib and Cobimetinib (c…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCobimetinibEntry “Vemurafenib and Cobimetinib (c…›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedHhAntag691Entry “Vismodegib”, read by our name …›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedRegorafenibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedNivolumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAfatinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedINT010009Entry “Dabrafenib and trametinib”, re…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedRibociclibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedLenvatinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPembrolizumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedDurvalumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedRucaparibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAxitinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPalbociclibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCrizotinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedSunitinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCabozantinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAbemaciclibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · TestedBackground · optionAlectinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedINT010133Entry “Atezolizumab and Bevacizumab”,…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedINT009997Entry “Ipilimumab and nivolumab”, rea…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedEntrectinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTalazoparibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedDacomitinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedLorlatinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedErdafitinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAlpelisibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedNiraparibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPemigatinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedSelpercatinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTepotinibIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedIpilimumabMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · TestedTestedAtezolizumabMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Panitumumab

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Panitumumab”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2PanitumumabClaude Opus 5.5TestedCurrent
Nov 2OlaparibClaude Opus 5.5TestedReplaced
Nov 2DabrafenibClaude Opus 5.5TestedCurrent
Nov 2NilotinibClaude Opus 5.5TestedCurrent
Nov 2TrametinibClaude Opus 5.5TestedCurrent
Nov 2ErlotinibClaude Opus 5.5TestedCurrent
Nov 2TrastuzumabClaude Opus 5.5TestedReplaced
Nov 2PertuzumabClaude Opus 5.5TestedReplaced
Nov 2VemurafenibClaude Opus 5.5TestedCurrent
Nov 2CobimetinibClaude Opus 5.5TestedReplaced
Nov 2HhAntag691Claude Opus 5.5TestedCurrent
Nov 2RegorafenibClaude Opus 5.5TestedCurrent
Nov 2NivolumabClaude Opus 5.5TestedReplaced
Nov 2AfatinibClaude Opus 5.5TestedCurrent
Nov 2INT010009Claude Opus 5.5TestedCurrent
Nov 2RibociclibClaude Opus 5.5TestedReplaced
Nov 2LenvatinibClaude Opus 5.5TestedCurrent
Nov 2PembrolizumabClaude Opus 5.5TestedCurrent
Nov 2DurvalumabClaude Opus 5.5TestedReplaced
Nov 2RucaparibClaude Opus 5.5TestedReplaced
Nov 2AxitinibClaude Opus 5.5TestedCurrent
Nov 2PalbociclibClaude Opus 5.5TestedReplaced
Nov 2CrizotinibClaude Opus 5.5TestedCurrent
Nov 2SunitinibClaude Opus 5.5TestedCurrent
Nov 2CabozantinibClaude Opus 5.5TestedReplaced
Nov 2AbemaciclibClaude Opus 5.5TestedReplaced
Nov 2AlectinibClaude Opus 5.5TestedReplaced
Nov 2INT010133Claude Opus 5.5TestedCurrent
Nov 2INT009997Claude Opus 5.5TestedCurrent
Nov 2EntrectinibClaude Opus 5.5TestedReplaced
Nov 2TalazoparibClaude Opus 5.5TestedCurrent
Nov 2DacomitinibClaude Opus 5.5TestedCurrent
Nov 2LorlatinibClaude Opus 5.5TestedCurrent
Nov 2ErdafitinibClaude Opus 5.5TestedCurrent
Nov 2AlpelisibClaude Opus 5.5TestedReplaced
Nov 2NiraparibClaude Opus 5.5TestedReplaced
Nov 2PemigatinibClaude Opus 5.5TestedCurrent
Nov 2SelpercatinibClaude Opus 5.5TestedCurrent
Nov 2TepotinibClaude Opus 5.5TestedCurrent
Nov 3OlaparibClaude Opus 5.5TestedCurrent
Nov 3TrastuzumabClaude Opus 5.5TestedCurrent
Nov 3PertuzumabClaude Opus 5.5TestedCurrent
Nov 3CobimetinibClaude Opus 5.5TestedCurrent
Nov 3NivolumabClaude Opus 5.5TestedCurrent
Nov 3RibociclibClaude Opus 5.5TestedCurrent
Nov 3DurvalumabClaude Opus 5.5TestedCurrent
Nov 3RucaparibClaude Opus 5.5TestedCurrent
Nov 3PalbociclibClaude Opus 5.5TestedCurrent
Nov 3CabozantinibClaude Opus 5.5TestedCurrent
Nov 3AbemaciclibClaude Opus 5.5Background · optionCurrent
Nov 3AlectinibClaude Opus 5.5TestedCurrent
Nov 3EntrectinibClaude Opus 5.5TestedCurrent
Nov 3AlpelisibClaude Opus 5.5TestedCurrent
Nov 3NiraparibClaude Opus 5.5TestedCurrent
Nov 3Ipilimumabmade hereClaude Opus 5.5TestedCurrent
Nov 3Atezolizumabmade hereClaude Opus 5.5TestedCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 18PanitumumabRule based · role ruleTestedAgrees
Nov 18OlaparibRule based · role ruleTestedAgrees
Nov 18DabrafenibRule based · role ruleTestedAgrees
Nov 18NilotinibRule based · role ruleTestedAgrees
Nov 18TrametinibRule based · role ruleTestedAgrees
Nov 18ErlotinibRule based · role ruleTestedAgrees
Nov 18TrastuzumabRule based · role ruleTestedAgrees
Nov 18PertuzumabRule based · role ruleTestedAgrees
Nov 18VemurafenibRule based · role ruleTestedAgrees
Nov 18CobimetinibRule based · role ruleTestedAgrees
Nov 18HhAntag691Rule based · role ruleTestedAgrees
Nov 18RegorafenibRule based · role ruleTestedAgrees
Nov 18NivolumabRule based · role ruleTestedAgrees
Nov 18AfatinibRule based · role ruleTestedAgrees
Nov 18INT010009Rule based · role ruleTestedAgrees
Nov 18RibociclibRule based · role ruleTestedAgrees
Nov 18LenvatinibRule based · role ruleTestedAgrees
Nov 18PembrolizumabRule based · role ruleTestedAgrees
Nov 18DurvalumabRule based · role ruleTestedAgrees
Nov 18RucaparibRule based · role ruleTestedAgrees
Nov 18AxitinibRule based · role ruleTestedAgrees
Nov 18PalbociclibRule based · role ruleTestedAgrees
Nov 18CrizotinibRule based · role ruleTestedAgrees
Nov 18SunitinibRule based · role ruleTestedAgrees
Nov 18CabozantinibRule based · role ruleTestedAgrees
Nov 18AbemaciclibRule based · role ruleTestedOverridden
Nov 18AlectinibRule based · role ruleTestedAgrees
Nov 18INT010133Rule based · role ruleTestedAgrees
Nov 18INT009997Rule based · role ruleTestedAgrees
Nov 18EntrectinibRule based · role ruleTestedAgrees
Nov 18TalazoparibRule based · role ruleTestedAgrees
Nov 18DacomitinibRule based · role ruleTestedAgrees
Nov 18LorlatinibRule based · role ruleTestedAgrees
Nov 18ErdafitinibRule based · role ruleTestedAgrees
Nov 18AlpelisibRule based · role ruleTestedAgrees
Nov 18NiraparibRule based · role ruleTestedAgrees
Nov 18PemigatinibRule based · role ruleTestedAgrees
Nov 18SelpercatinibRule based · role ruleTestedAgrees
Nov 18TepotinibRule based · role ruleTestedAgrees
As of nowNeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.